Silver Book Fact

Stem Cell Therapy Study Shows Improved Motor Function in Parkinson’s

Fact image

Scheiss M, Suescun J, Ellmore T, et al. Preliminary Report on the Safety and Tolerability of Bone Marrow-Derived Allogenic Mesenchymal Stem Cells Infused Intravenously in Parkinson’s Disease Patients; 2019. http://indexsmart.mirasmart.com/AAN2019/PDFfiles/AAN2019-003060.pdf. Accessed June 11, 2019

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • A study of Parkinson’s disease treatments found that pramipexole is a cost-effective treatment for early and advanced Parkinson’s disease. The total cost-effectiveness ratio was $8,837/QALY for patients with early Parkinson’s…  
  • Medicare Costs, 5-Year Delayed Onset  
  • The U.S. Food and Drug Administration has approved five drugs that temporarily improve Alzheimer’s disease symptoms.  
  • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2020 Medicare costs for people with the disease would be…  
  • In one study, Alzheimer’s patients who took donepezil had an increase in their prescription costs of $1,000 per patient, but saw reduced total medical costs of about 1/3–from $11,947 to…